Bilateral Patellar Metastases from Non-small Cell Lung Cancer  by Teh, Amy Yuen Meei et al.
IMAGE OF THE MONTH
Bilateral Patellar Metastases from Non-small Cell
Lung Cancer
Amy Yuen Meei Teh, MBBS, BSc (Med),† David Ball MD, FRANZCR,†
Robin Cassumbhoy, FRANZCR,† and Sam Guglani FRCR‡
(J Thorac Oncol. 2007;2: 79–80)
Patellar metastases are rare. A literature review revealedonly approximately seven reported cases of patellar me-
tastases from lung cancer, many of which were adenocarci-
nomas, with one epidermoid carcinoma and one small cell
carcinoma. Other reported cases originated from the salivary
gland, floor of the mouth, breast, bladder, colon, and renal
cell carcinoma.
Bilateral patellar metastases are even less common. There
is only one other reported case of bilateral patellar metastases
originating from the lung, a bronchogenic adenocarcinoma.1 In
this article, we present another such a case.
CASE REPORT
A 63-year-old woman with a life-time history of smok-
ing, presented with rapid weight loss and hemoptysis and was
diagnosed with a 6-cm left upper lobe non-small cell lung
cancer, most likely poorly differentiated squamous cell car-
cinoma, on computed tomographic guided biopsy. She had a
history of right breast cancer diagnosed 15 years previously,
treated with mastectomy and tamoxifen.
Initial staging positron emission tomography and com-
puted tomography scans revealed only disease in the left
upper lobe with no evidence of loco-regional or distant
metastases. Two foci of focal uptake within the right trape-
zius and left serratus anterior muscles were noted on positron
emission tomography scan but were of uncertain significance.
In the 2 weeks after diagnosis, the patient deteriorated
rapidly. She developed significant pain and tenderness in her
left shoulder, both knees, and left ankle. Movements in these
joints resulted in severe pain, which greatly impaired func-
tion. Painful subcutaneous lesions also developed over her
left arm and scalp.
Inflammatory and immunological markers including
rheumatoid factor, anti-nuclear antibody, anti-ds-DNA anti-
bodies, and ANCA were all negative. ESR and CRP were
mildly elevated at 36 mm/hr (normal range, 1–20 mm/hr) and
38 mg/L (normal range, 0–10 mg/L), respectively. Radio-
graphs of the joints were essentially normal.
A bone scan (Figure 1) demonstrated mild diffuse
uptake throughout the skeleton, with more prominent uptake
along the knees, ankles, calcaneum, and left distal humeral
shaft, suggesting diffuse bone marrow expansion. These find-
ings are not consistent with hypertrophic pulmonary osteoar-
thropathy. Uptake was also noted in the region of the occip-
ital protuberance, which was thought more likely to represent
a benign bony island.
A magnetic resonance imaging scan of the knees (Fig-
ures 2 and 3) confirmed bilateral patellar metastases, with two
further bony metastases in the distal femur on the right and
associated small reactive joint effusions.
Under guidance of the palliative care team, the patients
received a combination of high-dose morphine with ketamine
infusion and a non-steroidal anti-inflammatory drug (ketoro-
lac, 60 mg subcutaneously over 24 hours) delivered subcu-
taneously in an attempt to achieve pain control. As the
patient’s pain continued to escalate, she also received metho-
trimeprazine, a neuroleptic drug with sedative and morphine-
potentiating properties, delivered subcutaeneously12.5 mg
twice a day.
Pain improved locally after palliative irradiation of the
left humerus (20 Gy in five fractions) and occiput (8 Gy in
one fraction). Palliative radiotherapy was also delivered to
the primary lesion in the left upper lobe (20 Gy in five
fractions). A response was not observed with a 90-mg pam-
idronate infusion, but this was administered 1 week before
the patient’s death.
Because of a decline in her general condition, the
patient was unable to tolerate further palliative radiotherapy.
She died 1 month after diagnosis.
This case not only demonstrates an uncommon presenta-
tion of metastatic disease but also illustrates the difficulty that
may be experienced in adequately palliating patients with this
disease in the setting of rapidly progressive end-stage cancer.
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FIGURE 1. Bone scan demonstrating wide-
spread uptake suggestive of bony metastases.
FIGURE 2. Sagittal magnetic resonance imaging scan of
the left knee demonstrating patellar metastasis (T1-weighted
image).
FIGURE 3. Sagittal magnetic resonance imaging scan of
the right knee demonstrating patellar metastasis (T1-
weighted image).
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